Sampo plc
Sampo plc’s share buybacks 31 October 2025
Sampo plc’s share buybacks 31 October 2025
Sampo plc, stock exchange release, 3 November 2025 at 8:30 am EET
Sampo plc’s share buybacks 31 October 2025
On 31 October 2025, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows:
| Sampo plc’s share buybacks | Aggregated daily volume (in number of shares) | Daily weighted average price of the purchased shares* | Market (MIC Code) |
| 7,240 | 9.72 | AQEU | |
| 111,363 | 9.72 | CEUX | |
| 36,894 | 9.72 | TQEX | |
| 140,071 | 9.72 | XHEL | |
| TOTAL | 295,568 | 9.72 |
* rounded to two decimals
On 6 August 2025, Sampo announced a share buyback programme of up to a maximum of EUR 200 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 7 August 2025, is based on the authorisation granted by Sampo's Annual General Meeting on 23 April 2025.
After the disclosed transactions, the company owns in total 20,484,833 Sampo A shares representing 0.76 per cent of the total number of shares in Sampo plc.
Details of each transaction are included as an appendix of this announcement.
On behalf of Sampo plc,
Morgan Stanley
For further information, please contact:
Sami Taipalus
Head of Investor Relations
tel. +358 10 516 0030
Distribution:
Nasdaq Helsinki
Nasdaq Stockholm
Nasdaq Copenhagen
London Stock Exchange
FIN-FSA
The principal media
www.sampo.com
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Stablecon3.11.2025 15:10:00 CET | Press release
Stablecon and Events Venture Group Announce Strategic Investment and European Expansion with New EMEA Conference in Amsterdam
Genmab A/S3.11.2025 15:05:00 CET | Press release
Genmab to Showcase Latest Blood Cancer Treatment Advancements at 2025 American Society of Hematology (ASH) Annual Meeting
Infoblox Inc.3.11.2025 15:00:00 CET | Press release
Infoblox Surpasses 200 Customers in Breakout Year for Universal DDI™ and Announces New Capabilities for Network Transformation
Evaxion3.11.2025 15:00:00 CET | Press release
Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate
F. Hoffmann-La Roche Ltd3.11.2025 15:00:00 CET | Press release
Roche to present new data from its broad and innovative haematology portfolio at ASH 2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom